Literature DB >> 12198322

Chronic mu-opioid receptor stimulation alters cardiovascular regulation in humans: differential effects on muscle sympathetic and heart rate responses to arterial hypotension.

Peter Kienbaum1, Thorsten Heuter, Norbert Scherbaum, Markus Gastpar, Jürgen Peters.   

Abstract

In opioid addicted patients, respiratory regulation adapts allowing intake of otherwise lethal dosages of opioids. In contrast, little is known about cardiovascular regulation during chronic opioid receptor stimulation. We previously demonstrated that chronic mu-opioid receptor stimulation by methadone decreases resting muscle sympathetic activity (MSA). However, for short-term control of arterial blood pressure autonomic responses to arterial hypotension may be of greater importance. Accordingly, we tested the hypothesis that chronic opioid receptor stimulation attenuates muscle sympathetic and heart rate responses to arterial hypotension. Ten young patients (mean +/- SD, 30 years +/- 6) with a long history of mono-opioid addiction and under oral methadone substitution therapy (54 mg d(-1) +/- 31) for 12 months (+/-20) were studied. Peroneal MSA (microneurography) and heart rate responses to hypotensive challenges (sodium nitroprusside) were assessed in the awake state and compared with those of 10 matched healthy subjects. Effects of mu-opioid receptor blockade by naloxone (12.4 mg i.v.) were determined during propofol anesthesia. Chronic mu-opioid receptor stimulation markedly decreased the MSA response to hypotension (-0.5 units mm Hg(-1) +/- 0.2 vs. -2.0 +/- 1.8; p = 0.01) compared with healthy subjects despite similar arterial blood pressure and heart rate at rest. In contrast, the heart rate response to hypotension did not differ between addicted patients (6 ms mm Hg(-1) +/- 2) and healthy subjects (7 ms mm Hg(-1) +/-4). Opioid receptor blockade during propofol anesthesia markedly increased the MSA response to hypotension even beyond awake values (-1.2 units mm Hg(-1) +/- 1.1; p = 0.02 vs. awake) while the heart rate response remained unchanged. Thus, chronic mu-opioid receptor stimulation 1) results in uncompensated depression of cardiovascular sympathetic neural regulation, and 2) exerts differential effects on efferent sympathetic nerve activity to muscle and on heart rate control in response to arterial hypotension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198322     DOI: 10.1097/00005344-200209000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers.

Authors:  Karen D Ersche; Jonathan P Roiser; Luke Clark; Mervyn London; Trevor W Robbins; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

2.  Effects of anesthetic and sedative agents on sympathetic nerve activity.

Authors:  Xiao Liu; Perry L Rabin; Yuan Yuan; Awaneesh Kumar; Peter Vasallo; Johnson Wong; Gloria A Mitscher; Thomas H Everett; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2019-06-25       Impact factor: 6.343

3.  Low-dose morphine reduces tolerance to central hypovolemia in healthy adults without affecting muscle sympathetic outflow.

Authors:  Joseph C Watso; Luke N Belval; Frank A Cimino; Bonnie D Orth; Joseph M Hendrix; Mu Huang; Elias Johnson; Josh Foster; Carmen Hinojosa-Laborde; Craig G Crandall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-22       Impact factor: 5.125

4.  Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.

Authors:  Elena Martínez-Laorden; Juan-Antonio García-Carmona; Alberto Baroja-Mazo; Paola Romecín; Noemí M Atucha; María-Victoria Milanés; María-Luisa Laorden
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Decreased heart rate variability responses during early postoperative mobilization--an observational study.

Authors:  Øivind Jans; Louise Brinth; Henrik Kehlet; Jesper Mehlsen
Journal:  BMC Anesthesiol       Date:  2015-08-22       Impact factor: 2.217

6.  Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal.

Authors:  Pilar Almela; Juan-Antonio García-Carmona; Elena Martínez-Laorden; María-Victoria Milanés; María-Luisa Laorden
Journal:  Front Pharmacol       Date:  2013-12-27       Impact factor: 5.810

7.  Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder.

Authors:  Virginia D Schmith; Laura Curd; Lauren R L Lohmer; Celine M Laffont; Anne Andorn; Malcolm A Young
Journal:  Clin Pharmacol Ther       Date:  2019-04-08       Impact factor: 6.875

Review 8.  Cardiac Protective Role of Heat Shock Protein 27 in the Stress Induced by Drugs of Abuse.

Authors:  Elena Martínez-Laorden; Javier Navarro-Zaragoza; María Victoria Milanés; María Luisa Laorden; Pilar Almela
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.